RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS

NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF

RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS

RETROTRANSPOSONS AND USE THEREOF

RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS

Synthetic active peptide fragments

Process for purification of a fatty acid binding protein

Synthetic active peptide fragments

Immune-modulating agents and uses therefor

Synthetic gene for expressing Sm-14 in , methods for producing and purifying Sm-14 and the use thereof as a vaccine and diagnostic medium

Direct or indirect diagnostic test for helminth infection

AUXOTROPHIC RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF IN THE CONTROL OF HUMAN INFECTIONS CAUSED BY PARASITES

HELMINTH ANTIGEN AND IMMUNOTHERAPY

Schistosomiasis vaccine compositions and methods of use

PROTEIN STABILIZATION

MEMBRANE PROTEIN SM29 OF SCHISTOSOMA MANSONI AND USES THEREOF FOR TREATING AND DIAGNOSING SCHISTOSOMIASIS

Synthetic active peptide fragments

Helminth-derived antigens having capacity of providing protection against parasites

Synthetic active peptide fragments

Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands